Rocket Pharmaceuticals Financial Overview
Rocket Pharmaceuticals's market cap is currently $349.56M. The company's EPS TTM is $-0.45; its P/E ratio is ―; Rocket Pharmaceuticals is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.
